Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
Open Access
- 9 September 2009
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 9 (1) , 44
- https://doi.org/10.1186/1471-2466-9-44
Abstract
Tigecycline, an expanded broad-spectrum glycylcycline, exhibits in vitro activity against many common pathogens associated with community-acquired pneumonia (CAP), as well as penetration into lung tissues that suggests effectiveness in hospitalized CAP patients. The aim of the present study was to compare the efficacy and safety of intravenous (IV) tigecycline with IV levofloxacin in hospitalized adults with CAP.Keywords
This publication has 27 references indexed in Scilit:
- Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999–2003)Diagnostic Microbiology and Infectious Disease, 2006
- Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countriesDiagnostic Microbiology and Infectious Disease, 2006
- Functional, Biophysical, and Structural Bases for Antibacterial Activity of TigecyclineAntimicrobial Agents and Chemotherapy, 2006
- The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial DataClinical Infectious Diseases, 2005
- The Efficacy and Safety of Tigecycline in the Treatment of Skin and Skin‐Structure Infections: Results of 2 Double‐Blind Phase 3 Comparison Studies with Vancomycin‐AztreonamClinical Infectious Diseases, 2005
- Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumoniaDiagnostic Microbiology and Infectious Disease, 2005
- Comparative Antimicrobial Susceptibility of Respiratory Tract PathogensChemotherapy, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Community-acquired pneumonia in Europe: causative pathogens and resistance patternsEuropean Respiratory Journal, 2002
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000